Filtros de búsqueda

Lista de obras de Antonella De Luca

A “live” biopsy in a small-cell lung cancer patient by detection of circulating tumor cells

article by Simona Bevilacqua et al published July 2009 in Lung Cancer

AZD3409 inhibits the growth of breast cancer cells with intrinsic resistance to the EGFR tyrosine kinase inhibitor gefitinib.

artículo científico publicado en 2006

Anticancer effect of bisphosphonates: new insights from clinical trials and preclinical evidence.

artículo científico publicado en 2011

Assessment of high-sensitive methods for the detection of EGFR mutations in circulating free tumor DNA from NSCLC patients

artículo científico publicado en 2015

Breast cancer cells with acquired resistance to the EGFR tyrosine kinase inhibitor gefitinib show persistent activation of MAPK signaling

artículo científico publicado en 2007

Circulating programmed death ligand-1 (cPD-L1) in non-small-cell lung cancer (NSCLC).

artículo científico publicado en 2018

Clinical utility of circulating tumor cells in patients with non-small-cell lung cancer

artículo científico publicado en 2017

Cripto-1 activates nodal- and ALK4-dependent and -independent signaling pathways in mammary epithelial Cells

artículo científico publicado en 2002

Cripto-1 overexpression leads to enhanced invasiveness and resistance to anoikis in human MCF-7 breast cancer cells

artículo científico publicado en 2004

Detection and localization of Cripto-1 binding in mouse mammary epithelial cells and in the mouse mammary gland using an immunoglobulin-cripto-1 fusion protein

artículo científico publicado en 2002

Detection of EGFR mutations by TaqMan mutation detection assays powered by competitive allele-specific TaqMan PCR technology

artículo científico publicado en 2013

EGF-related antisense oligonucleotides inhibit the proliferation of human ovarian carcinoma cells

artículo científico publicado en 2000

EGFR and MEK Blockade in Triple Negative Breast Cancer Cells.

artículo científico publicado en 2015

EGFR mutations in lung cancer: from tissue testing to liquid biopsy

artículo científico

Effects of the combined blockade of EGFR and ErbB-2 on signal transduction and regulation of cell cycle regulatory proteins in breast cancer cells.

artículo científico publicado en 2009

Epidermal growth factor receptor (EGFR) tyrosine kinase inhibitors in breast cancer: current status and future development

artículo científico publicado en 2005

Erlotinib in pancreatic cancer: are tumor cells the (only) target?

artículo científico publicado en 2007

Evaluation of the pharmacokinetics of ixabepilone for the treatment of breast cancer.

artículo científico

Expression and functional role of CRIPTO-1 in cutaneous melanoma

artículo científico publicado el 23 de agosto de 2011

Extracellular matrix proteins as circulating biomarkers for the diagnosis of non-small cell lung cancer patients.

artículo científico publicado en 2019

FGFR-targeted therapeutics for the treatment of breast cancer.

artículo científico publicado en 2017

Gefitinib inhibits the ability of human bone marrow stromal cells to induce osteoclast differentiation: implications for the pathogenesis and treatment of bone metastasis

artículo científico publicado en 2005

Gefitinib inhibits the cross-talk between mesenchymal stem cells and prostate cancer cells leading to tumor cell proliferation and inhibition of docetaxel activity.

artículo científico publicado en 2013

Gene methylation in liquid biopsy and risk of recurrence in lung cancer.

artículo científico publicado en 2018

Genomic Profiling of KRAS/NRAS/BRAF/PIK3CA Wild-Type Metastatic Colorectal Cancer Patients Reveals Novel Mutations in Genes Potentially Associated with Resistance to Anti-EGFR Agents

scientific article published on 20 June 2019

Identification of cripto-1 as a novel serologic marker for breast and colon cancer.

artículo científico publicado en 2006

Implications for KRAS status and EGFR-targeted therapies in metastatic CRC.

artículo científico publicado en 2009

Is the gefitinib plus trastuzumab combination feasible in breast cancer patients?

artículo científico publicado en 2005

Limits and potential of targeted sequencing analysis of liquid biopsy in patients with lung and colon carcinoma.

scientific article published on 19 July 2016

Mechanisms of endocrine resistance and novel therapeutic strategies in breast cancer

artículo científico publicado en 2005

Mesenchymal stem cell‐derived interleukin‐6 and vascular endothelial growth factor promote breast cancer cell migration

artículo científico publicado en 2012

Modulation of Epidermal Growth Factor Receptor–Positive Circulating Tumor Cells by Chemotherapy in Non–Small-Cell Lung Cancer Patients

scientific article published on 01 October 2005

Molecular diagnostics and personalized medicine in oncology: Challenges and opportunities

artículo científico publicado en 2013

Pharmacokinetic drug evaluation of palbociclib for the treatment of breast cancer

artículo científico publicado en 2018

Pharmacokinetic evaluation of zoledronic acid.

artículo científico publicado en 2011

Prognostic applications of gene expression signatures in breast cancer

artículo científico publicado en 2009

Prognostic value of circulating tumor cells' reduction in patients with extensive small-cell lung cancer

artículo científico publicado en 2014

Quercetin‐3‐methyl ether inhibits lapatinib‐sensitive and ‐resistant breast cancer cell growth by inducing G2/M arrest and apoptosis

artículo científico publicado el 15 de noviembre de 2011

RANTES and IL-6 cooperate in inducing a more aggressive phenotype in breast cancer cells

artículo científico publicado en 2018

Role of the EGFR ligand/receptor system in the secretion of angiogenic factors in mesenchymal stem cells

artículo científico publicado en 2011

Simultaneous blockage of different EGF-like growth factors results in efficient growth inhibition of human colon carcinoma xenografts.

artículo científico publicado en 2000

Src and CXCR4 are involved in the invasiveness of breast cancer cells with acquired resistance to lapatinib

artículo científico publicado en 2013

Structure-fluctuation-function relationships of seven pro-angiogenic isoforms of VEGFA, important mediators of tumorigenesis

artículo científico publicado en 2015

Target-based therapies in breast cancer: current status and future perspectives.

scientific article published on 12 June 2009

Targeting the EGFR T790M mutation in non-small-cell lung cancer

artículo científico publicado en 2016

The ErbB receptors and their ligands in cancer: an overview.

artículo científico publicado en 2005

The MEK/MAPK pathway is involved in the resistance of breast cancer cells to the EGFR tyrosine kinase inhibitor gefitinib

artículo científico publicado en 2006

The Presence of Concomitant Mutations Affects the Activity of EGFR Tyrosine Kinase Inhibitors in EGFR-Mutant Non-Small Cell Lung Cancer (NSCLC) Patients

artículo científico publicado en 2019

The RAS/RAF/MEK/ERK and the PI3K/AKT signalling pathways: role in cancer pathogenesis and implications for therapeutic approaches.

artículo científico

The liquid biopsy in the management of colorectal cancer patients: Current applications and future scenarios

artículo científico publicado en 2018

The potential of monitoring treatment response in non-small cell lung cancer using circulating tumour cells

artículo científico publicado en 2019

The prognostic role of circulating tumor cells in lung cancer.

artículo científico publicado en 2016

The role of EGF-related peptides in tumor growth.

artículo científico publicado en 2001

The role of the EGFR signaling in tumor microenvironment.

artículo científico publicado en 2008

VEGF as a potential target in lung cancer

artículo científico publicado en 2017

Vandetanib as a potential treatment for breast cancer.

artículo científico

Vascular Endothelial Growth Factor A Regulates the Secretion of Different Angiogenic Factors in Lung Cancer Cells

artículo científico publicado en 2015

Zoledronic acid blocks the interaction between mesenchymal stem cells and breast cancer cells: implications for adjuvant therapy of breast cancer.

artículo científico publicado en 2011

Zoledronic acid in early-stage breast cancer

artículo científico publicado en 2011